New Device Can Check Markers for Parkinson's, Alzheimer's Disease

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- A wireless, noninvasive device has shown promise in detecting the biomarkers of Alzheimer’s and Parkinson’s diseases.

Researchers said the device uses electrical detection to identify proteins associated with Alzheimer’s (amyloid beta and tau) and Parkinson’s (alpha synuclein) in saliva and urine.

“This portable diagnostic system would allow testing at-home and at point of care, like clinics and nursing homes, for neurodegenerative diseases globally,” co-researcher Ratnesh Lal, a professor at the University of California-San Diego Jacobs School of Engineering, said in a university news release.

The device contains a chip with a high-sensitivity transistor that uses DNA to detect amyloid beta, tau or synuclein proteins, researchers said.

Lal said electrical detection is easier to implement and more accurate than chemical detection. He also wanted to create a device that could wirelessly transmit test results to a laptop or smartphone.

Tests on proteins derived from the brains of deceased Alzheimer’s and Parkinson’s patients showed that the biosensors were able to detect specific biomarkers for both conditions with great accuracy, on par with existing methods, findings show.

The device also works well even when samples contain other types of protein, researchers said. Because it works at extremely low concentrations, only small samples are needed, they added.

Tau proteins proved more difficult to detect, but the device can combine results of all three biomarkers to arrive at a reliable overall result, the study found.

UC San Diego has licensed the technology to a biotechnology startup called Ampera Life. Lal is the company’s chairman but does not receive financial support for his research from the company.

Researchers next plan to test blood and cerebro-spinal fluid with the device, before proceeding to saliva and urine samples. The tests would take place in hospital settings and nursing homes.

If those tests go well, Ampera Life plans to seek U.S. Food and Drug Administration approval for the device within the next five to six months. The goal is to have the device on the market in a year.

The findings were published Nov. 13 in the Proceedings of the National Academy of Sciences

Sources

  • University of California-San Diego, news release, Nov. 13, 2023

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-11-17 22:48

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords